Example logo GIS 26

Global Innovation Summit 2026

6 May 2026 | Basel, Switzerland

Home

Xilis

SME

www.xilis.comUtrecht, Netherlands
3 profile visits

About

Xilis is a precision oncology company that developed MicroOrganoSphere™ technology, a patient-derived organoid platform designed to support functional precision oncology, translational cancer research and therapy-response testing.

Xilis B.V. is the company’s Dutch subsidiary. The European site has supported scientific, operational and translational activities connected to the MicroOrganoSphere™ platform, including work at the interface of oncology biology, patient-derived models, translational research and drug development.

For the Global Innovation Summit, the organisation profile is intended to provide factual background on Xilis and its technology. Meeting requests should be directed to Christoph Lampert, VP & Site Head, whose current focus at the event is reconnecting with the Swiss biotech and innovation ecosystem and exploring senior leadership opportunities in Switzerland.

Social media

What is your business/industry sector?

Biotech, Pharma and Cosmetics

Representatives

Christoph Lampert

Vice President & Site Head | Biophamaceutical Executive

Xilis